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Pulmonary artery hypertension
Cardiovascular magnetic resonance image
EchocardiographyBackground and objective: Assessment of RV function is complex and no single measurement is generally
accepted in clinical practice, so PH is often diagnosed at a late stage of the disease, and is associated with
poor survival. Cardiovascular magnetic resonance (CMRI) has become accepted as the gold standard tech-
nique for the assessment of the proximal pulmonary circulation and right ventricular function. It provides
information about the right heart structure, volumes and function that is not readily obtained by other
methods such as echocardiography and RHC. The aim of this study was to evaluate the diagnostic accu-
racy of a variety of CMR parameters as a non-invasive monitoring to study the right ventricular function
and morphology in patients with PAH and if it has a role in early recognition and treatment important to
improve long-term outcomes.
Patients and methods: This study included 40 patients with clinically suspected pulmonary hypertension.
All were subjected to full clinical history and examination, laboratory investigations, echocardiography
and CMRI.
Results: In the present study; there was highly significant positive correlation between RVEDV, RV mass
index, RV mass and VMI with SPAP, mPAP and PVR, but highly significant statistical negative correlation
between RVEF% and average velocity compared to SPAP, mPAP and PVR, RVSV. The most accurate CMRI
indices for the detection of PH in the present study were VMI, RV mass index followed by RVEF and aver-
age velocity with their PPVs were 99%, 98%, 95% and 95% respectively.
Conclusions: CMR imaging is likely to increase in importance as the optimal reference method for assess-
ment of early structural (morphological) and functional parameters of the right ventricle for evaluation of
patients with suspected PH valuable for assessment of treatment response, follow up and prognosis.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction artery pressure (MPAP) of P25 mm at rest as assessed by right-Pulmonary hypertension (PH) is a hemodynamic and patho-
physiologic condition defined as an increase in mean pulmonaryheart catheterization (RHC) [1]. A progressive rise in pulmonary
vascular resistance (PVR) results from obliteration or obstruction
of pulmonary vascular bed leading to a rise in pulmonary artery
pressure (PAP); these vascular changes result in increased after-
load to the right ventricle (RV) which initially undergoes adaptive
hypertrophy, but later experience maladaptive dilatation, fibrosis
and valve regurgitation resulting in right ventricular failure and
early death [2]. Pulmonary arterial hypertension is most often
diagnosed in its advanced stages because of the nonspecific nature
of early symptoms and signs. In patients with PAH an increase in
mPAP and pulmonary vascular resistance (PVR) results in right
ventricular failure and death with a median survival in untreated
patients of less than 3 years. Pulmonary vascular resistance (PVR)
has important implications in the diagnostic evaluation and
prognosis of patients with pulmonary hypertension (PH) [3]. Theht ven-
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PH. It is unknown why some patients with markedly elevated
MAP maintain well-preserved cardiac function for several years,
while others with equal or less severe PH suffer rapidly progressive
right heart failure. Lack of techniques that give a reliable picture of
right ventricular morphological and functional changes hinders the
possible early recognition of PH that may improve prognosis and
survival of patients [4]. Currently, quantification of PVR requires
invasive right heart catheterization (RHC) which is the gold stan-
dard test used to assess for the presence or absence of PH by
directly measuring mPAP and allows measurement of cardiac out-
put (CO) and index (CI), right atrial pressure, mixed venous oxygen
saturation and PVR, which are used as markers of disease severity
[5]. However, although safe in expert hands it is an invasive test
and its role is limited to confirming a diagnosis of PH and assessing
the response to treatment. Although clinical assessment is essen-
tial when evaluating patients with suspected pulmonary arterial
hypertension, echocardiography is a key screening tool in the diag-
nostic algorithm [6]. An accurate non-invasive method for mea-
surement of PVR would be helpful to eliminate the discomfort,
radiation exposure, and small but real risk of morbidity and mor-
tality associated with RHC [7]. Doppler echocardiography has
become routine in the non-invasive estimation of systolic
pulmonary arterial pressure (PAP), but is not widely accepted for
estimation of PVR because of inconclusive and conflicting data
[8]. Echocardiography is currently the most commonly used nonin-
vasive test in patients with suspected PH, however, this technique
has a number of limitations and does not perform well for certain
aetiologies of PH [9], significantly over and underestimating inva-
sively measured mPAP. Consequently, there is increasing interest
in developing other non-invasive imaging tools [10]. Cardiac mag-
netic resonance (CMR) has been proposed as an alternative to
echocardiography in assessing pulmonary circulation haemody-
namics [11]. Because of its ability to accurately evaluate both right
ventricular (RV) and pulmonary artery (PA) anatomy and function,
CMR offers the potential for PVR quantification [12]. Preliminary
studies have shown significant correlations between several
CMR-derived parameters and RHC-quantified PVR [13]. It is
hypothesized that a model based on CMR could allow for non-
invasive estimation of absolute PVR values [14]. Several studies
have shown significant relationships between cardiovascular mag-
netic resonance (CMR) derived measurements with mPAP and PVR
in patients with PH; including ventricular mass index (VMI), inter-
ventricular septal configuration, pulmonary arterial blood flow
quantification and pulsatility [15]. One of the advantages of CMR
is that it provides anatomical measurements and indexes that are
not influenced by factors and variables affecting echocardiography,
such as detectable tricuspid regurgitation, body habitus, coexisting
lung disease, heart rate, posture and hydration status. (Some of
these limitations also affect the accepted gold standard method
of right heart catheterisation). These anatomical indexes are
related to haemodynamic parameters clinically relevant to PAH
severity, such as the mean pulmonary arterial pressure. The ven-
tricular mass index (ratio of RV mass to left ventricular mass) is
such a CMR- derived variable, which provides an accurate and
practical means of estimating pulmonary artery pressure non-
invasively in pulmonaryhypertension and may provide a more
accurate estimate than Doppler echocardiography [16]. Recently,
developments in hardware and software have enabled CMR guid-
ance of endovascular catheters under real-time imaging (magnetic
resonance fluoroscopy) [17]. This CMR approach is a promising tool
for assessing RV contractility in the clinical setting and quantifying
pulmonary vascular resistance more accurately, leading to better
treatment of patients with PAH [18]. Previous studies have demon-
strated that TTE and CMR had complementary advantages. TTE had
the potential to estimate mean pulmonary arterial pressurePlease cite this article in press as: E.R. Ali, A.M. Mohamad, Diagnostic accuracy
tricular morphology and function in pulmonary artery hypertension, Egypt. J.(MPAP) and pulmonary capillary wedge pressure (PCWP) reliably
[19]. In the non-invasive measurement of cardiac output (CO),
however, CMR had more accuracy and reproducibility than TTE.
Based on the formula (MPAP–PCWP)/CO, it became possible to cal-
culate PVR directly with TTE-derived (MPAP–PCWP) and CMR
derived CO. Therefore, we hypothesized that the combined use of
TTE and CMR might have the potential to estimate PVR non-
invasively. This study was performed to determine whether the
integrated modality formed a reliable non-invasive method to
measure PVR in PAH [20]. Over the last decade, CMRI has become
accepted as the gold standard technique for the assessment of the
proximal pulmonary circulation and right ventricular function as it
is a non-invasive tool that provides high resolution three dimen-
sional images of the heart. It provides information about the right
heart structure, volumes and function that is not readily obtained
by other methods such as echocardiography and RHC [21]. Evalua-
tion of right ventricular function is essential in the management of
patients with pulmonary hypertension. Current methods of assess-
ment of PH patients are suboptimal. The right ventricle is difficult
to assess due to its position and geometry. Recent developments in
imaging techniques, such as cardiac magnetic resonance (CMR)
imaging and echocardiography, have improved our understanding
of the structure and function of the right ventricle. Assessment of
RV function is complex and no single measurement is generally
accepted in clinical practice, so PH is often diagnosed at a late stage
of the disease, and is associated with poor survival; CMRI is
regarded as the ‘‘gold standard” for quantifying ventricular volume,
mass, structure and function. Impressive results for accuracy have
been demonstrated by several investigators in various disease
states [22]. The inter-study reproducibility of CMR-derived param-
eters of ventricular function and mass is good for both the left and
right ventricle and is superior to two-dimensional and M mode
echocardiography. The insertion-region architecture is exagger-
ated in pulmonary hypertension by hypertrophy of the right ven-
tricle and IVS coupled to shear forces arising from paradoxical
IVS motion and speculate that LGE is related to contrast pooling
within areas of myocardial disarray and the plexiform fibrosis
therein. This would explain why LGE occurs in the mid-
myocardium in quantities related to indexed RV mass. Disruption
of the mid-septum’s normally orderly fiber orientation may
account for the mid-septal extension of LGE in paradoxical IVS
motion. LGE-CMR relies on the delivery of intravenous gadolinium
chelate to the myocardium, which is a biologically inert tracer that
freely distributes in extracellular space but does not cross the
intact cell membrane. Due to a combination of increased extracel-
lular volume and slower washout kinetics, there is a relative accu-
mulation of gadolinium in areas of necrosis, fibrosis, infiltration,
and inflammation in the late washout phase [23]. The aim of this
study was to evaluate the diagnostic accuracy of a variety of
CMR parameters as a non-invasive monitoring to study the right
ventricular function and morphology in patients with suspected
PAH and if it has a role in early recognition and treatment impor-
tant to improve long-term outcomes.Patients and methods
Study patients
Inclusion criteria
From January 2013 to January 2015, a total of 40 patients were
enrolled in the present study who had undergone investigation for
assessment and diagnosis of suspected PH. Patients with suspected
PH also underwent detailed history and full clinical evaluation
(usually presented with dyspnea, mostly exertional on less than
their ordinary efforts or even dyspnea at rest, orthopnea and fati-of cardiovascular magnetic resonance imaging for assessment of right ven-
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testing, arterial blood gases (ABGs), CXR, computed tomography
scanning, lung function testing, exercise testing, ECG, transthoracic
echocardiogram, cardiac magnetic resonance imaging. Diagnostic
classification of the form of PH was by standard criteria following
multidisciplinary assessment WHO functional class status. They
were referred from cardiology and chest departments for further
radiological assessment in Ain Shams University Hospitals.
Patients had to fulfill the following criteria: sinus heart rhythm
and able to hold breath for accepted time (10–20 s). Written
informed consents were obtained from all patients.
Exclusion criteria
Patients with unstable clinical condition, severe or significant
co-morbidity, hemodynamic instability, orthopnic and severely
dyspnic patients (could not lie along the time of examination and
could not obey breathing instructions), inadequate image quality,
arrhythmia (such as atrial fibrillation, frequent premature beats
and so on), significant mitral or aortic regurgitation, variations of
heart rate and blood pressure P10% (between RHC/TTE and
CMR), and contraindications of CMR examination (claustrophobia,
patients with pacemaker and metal implants) were all excluded
from the study. For the patients aged P45 years, coronary artery
disease was excluded with selective coronary angiography
(defined as P50% reduction in lumen diameter). Claustrophobia
causing inability to tolerate CMR was also an exclusion from the
study.
Study design
The diagnosis of PH is based on RHC in accordance with con-
temporary guidelines PH was defined as an increase in mean pul-
monary arterial pressure (mPAP) P25 mmHg at rest, with a
PCWP 615 mmHg at rest and PVR >3 Wood units. The term ‘‘PAH”
is used specifically for WHO group I disease whereas ‘‘PH” is used
as a general term to describe any group [24]. TTE and CMR vari-
ables obtained were blinded to each other’[s calculations. For
inter-observer reproducibility, TEE and CMR were validated by
two independent observers based on the same imaging result
(without any communication) (Table 1).
Trans-thoracic echocardiography (TTE)
TTE (Philips IE33, instrument equipped with a 3–5 MHz trans-
ducer) was performed. TTE derived MPAP was calculated as TTE-
derived SPAP  0.61 + 2 mmHg, according to Chemla et al. [25].
SPAP was estimated by TTE from the systolic right ventricular-to-
right atrial pressure gradient using the modified Bernoulli equa-
tion. Furthermore, isovolumic relaxation time (IVRT) and color
M-mode Doppler flow propagation velocity (FPV) were measured
[26]. According to the recommendations in guideline, the measure-
ments of stroke volume (SV) and CO (SV heart rate) were made at
the level of the left ventricular (LV) outflow tract [27]. Although
there is no single echocardiographic measurement that can diag-Table 1
World Health Organisation functional classification in pulmonary hypertension.
Class I: Patients with PH but without resulting limitation of physical activity. Ordinar
syncope
Class II: Patients with PH resulting in slight limitation of physical activity. They are c
chest pain, or near syncope
Class III: Patients with PH resulting in marked limitation of physical activity. They are c
chest pain, or near syncope
Class IV: Patients with PH with inability to carry out any physical activity without sy
fatigue may even be present at rest. Discomfort is increased by any physical activ
PH; pulmonary hypertension.
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ity (TRV) can be used if PH is suspected [28]. In their 2015
guidelines for the diagnosis and treatment of PH, the joint task
force of the European Society of Cardiology (ESC) and the European
Respiratory Society (ERS) recommend grading the probability of PH
based on TRV at rest and the presence of additional echo variables
[29]. For measurement of pulmonary arterial systolic pressure,
echo shows good correlation with RHC [30]. However, echo cannot
be relied on for quantification and assessment of RV systolic func-
tion [31], and data suggest patients could be missed when this
method is used in isolation from other techniques during screening
[32]. Data collected from echocardiography included SPAP (systolic
pulmonary artery pressure) which was obtained directly, but
mPAP was obtained indirectly by using equation (mPAP = 0.61 
SPAP + 2).
Cardiac magnetic resonance (CMR)
Imaging protocol
All examinations were performed on a 1.5 Tesla MR scanner
(Magnetom Avanto, Siemens Medical Solutions, Erlangen,
Germany) at rest [33]. In brief, scout images acquired by using
half-Fourier acquisition single shot turbo spin-echo (HASTE)
sequence were used to analyze the morphology and structure of
the heart. Retrospective electrocardiographic gating cine images
were acquired using a true fast imaging with steady state preces-
sion sequence. For the volumetric and functional measurements,
contiguous short-axis images through the entire ventricle (from
base to apex, no gap) were obtained. Fast imaging with steady state
sequences were used to generate the initial axial, sagittal and coro-
nal scout images required to localize the heart within the thoracic
cavity and plan all subsequent cine images.
Phase contrast velocity mapping
Flow measurements were performed to pulmonary arteries and
ascending aorta through plane using a velocity-encoded phase con-
trast imaging sequence with specific image parameters. Images
were acquired during period of breath holding or with signal aver-
aging for those subjects unable to cooperate with breath-hold
instructions. Imaging included; flow of the pulmonary artery, flow
of the right pulmonary artery, flow of the left pulmonary artery
and flow of the ascending aorta [34].
Late gadolinium enhancement CMR
Late enhancement images were qualitatively assessed for
hyper-intensity at the inter-ventricular septal hinge points or
along the septum as previously described. The presence or absence
of delayed enhancement was recorded. Late gadolinium-enhanced
(LGE) images taken 10 min after injection of 0.1 mmol/kg gadoli
nium–diethylenetriamine pentaacetic acid.
Image analysis
Images were transferred to workstation equipped with dedi-
cated cardiac software package. The axial plane was used for eval-y physical activity does not cause undue dyspnoea or fatigue, chest pain, or near
omfortable at rest. Ordinary physical activity causes undue dyspnoea or fatigue,
omfortable at rest. Less than ordinary activity causes undue dyspnoea or fatigue,
mptoms. These patients manifest signs of right heart failure. Dyspnoea and/or
ity
of cardiovascular magnetic resonance imaging for assessment of right ven-
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Table 2
Demographic data among the studied 40 patients.
Variables Mean ± SD
Gender –
Male 25/40 (62.5%)
Female 15/40 (37.5%)
Age (years) 43 ± 18
Weight (kg) 59 ± 16
Height (cm) 160 ± 13
SD; standard deviation, kg; kilogram, cm; centimeter.
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tricular functions. The endocardial borders of both ventricles were
traced manually from the short-axis images during end systole and
end diastole phase. Right and left ventricular masses were mea-
sured by manually tracing the epicardial and endocardial borders.
Ventricular mass index was measured by dividing right ventricular
mass over left ventricular mass. The motion of the septum in the
two cardiac phases was visually analyzed on short-axis and four-
chamber views. To quantify flow within the proximal pulmonary
trunk, right pulmonary artery, left pulmonary artery and ascending
aorta, a region of interest was drown manually around the vessel
lumen in each phase of the dataset using the gradient echo image;
contours were then correlated with the corresponding phase
image. The workstation calculated flow volumes within the vessel
by integrating the velocity within the region of interest over the
cardiac cycle [35]. The data collected from MRI included the fol-
lowings: cardiac morphology parameters included: RVEDVI, RV
mass index and VMI. Right heart functional indices included RVEF
and RVSVI. Phase contrast CMR parameters (flow variables)
included retrograde flow (PR) acceleration time AT, ejection time
(ET), average (mean) velocity, forward flow, backward flow and
net flow.Table 3
Ventricular volumes measured by MRI compared to the published ventricular
volumes and functions in normal population (normal references).
Variables (ventricular MRI
parameters)
Mean ± SD Normal
references
Significance (P
value)Statistical analysis
The numerical variables were initially given as the mean and
standard deviations for each parameter. Pearson correlation coeffi-
cients (r) between MRI and mean pulmonary artery pressure
obtained from echo were calculated. Categorical variables were
presented as counts with percentages and compared by Chi-
square test or Fisher’s exact test. Continuous variables were pre-
sented as mean ± SD or median with IQR and compared by grouped
t-test or Wilcoxon rank sumtest. Pearson or spearman correlation
coefficients were calculated first and linear regression models were
constructed. Furthermore, Bland–Altman analysis was carried out
for agreement assessments, the lower and upper limits of agree-
ment were estimated, as the mean ±2SDs with 95% confidence
interval (CI). Pearson’s or Spearman’s correlation and Bland–Alt-
man analysis were also used to assess the intra-observer and
inter-observer reproducibility. A significance level of P < 0.05 was
used in all tests. Statistical software used in this study was SPSS
16.0 and MedCalc 9.5.RVEDV (ml) 160 ± 56 144 ± 23 S
RVEDVI (ml/m2) 95 ± 25 78 ± 11 S
RVESV (ml) 80 ± 34 50 ± 14 HS
RVESVI (ml/m2) 55 ± 68 27 ± 7 HS
RVSV (ml) 73 ± 20 94 ± 15 S
RVSVI (l/min/m2) 42 ± 14 51 ± 7 S
RVEF% 43 ± 12 66 ± 6 HS
RV mass 68 ± 34 48 ± 13 HS
RV mass index 46 ± 17 31 ± 6 S
LVEDV (ml) 124 ± 34 142 ± 21 NS
LVEDVI (ml/m2) 77 ± 12 78 ± 9 NS
LVESV (ml) 59 ± 19 47 ± 10 NS
LVESVI (ml/m2) 37 ± 12 26 ± 5 NS
LVSV (ml) 69 ± 23 95 ± 14 S
LVSVI (l/min/m2) 35 ± 29 52 ± 6 S
LVEF% 57 ± 12 67 ± 5 NS
LV mass 92 ± 22 127 ± 19 HS
RVEDV; right ventricular end diastolic volume, RVEDVI; right ventricular end
diastolic volume index, RVESV; right ventricular end systolic volume, RVEDVI; right
ventricular end systolic volume index, RVSV; right ventricular stroke volume,
RVSVI; right ventricular stroke volume index, RVEF%; right ventricular ejection
fraction, LVEDV; left ventricular end diastolic volume, LVEDVI; left ventricular end
diastolic volume index, LVESV; left ventricular end systolic volume, LVEDVI; left
ventricular end systolic volume index, LVSV; left ventricular stroke volume, LVSVI;
left ventricular stroke volume index, LVEF%; left ventricular ejection fraction, SD;
standard deviation, ml; milliliter, min; minute, l; liter, NS; non-significant, S; sig-
nificant, HS; highly significant.Results
The present study included 40 patients with clinically sus-
pected pulmonary hypertension; 25/40 (62.5%) of them were
males and the remaining 15/40 (37.5%) were females. The mean
age (years) ± SD was 43 ± 18, while the mean weight (kg) ± SD
was 59 ± 16 and the mean height (cm) ± SD was 160 ± 13 (Table 2).
In the present study; ventricular (right and left) volumes,
masses and functions by MRI were compared to the published ven-
tricular volumes and functions in normal population according to
Bogaert et al. [36] as shown in Table 3. As regards right ventricular
parameters measured by CMRI, there was a statistically significant
increase in RVEDV and RVEDVI but highly significant increase in
RVESV and RVESVI when compared to the normal reference values.
Statistically significant decrease was found in RVSV and RVSVI and
highly significant decrease regarding RVEF% in relation to the stan-
dard normal reference values. Highly significant statistical increase
in RV mass, but RV mass showed only significant increase as com-
pared with the reference values. Regarding the left ventricular
parameters measured by CMRI, there was a statistically non signif-
icant increase in LVEDV, LVEDVI, LVESV and LVESVI when com-
pared to the normal reference values. Statistically significantPlease cite this article in press as: E.R. Ali, A.M. Mohamad, Diagnostic accuracy
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values. Non-significant decrease in LVEF% as compared to the stan-
dard normal reference values. On the other hand; highly significant
statistical decrease in LV mass was found among the included
patients in relation to normal reference values (Table 3).
In the present study; mean values of the flow variables (pul-
monary artery flow data) measured by CMRI among the studied
patients were compared to the published flow variables in normal
population according to Swift et al. [37] as shown in Table 4. There
was highly significant statistical decrease in acceleration time (AT)
and ejection time (ET) and only significant decrease in the average
velocity and AT/ET ratio compared to the published flow variables
in normal population. Retrograde flow (PR) was significantly
higher than the normal reference values. Forward flow was signif-
icantly less than the normal values, while backward flow showed
non- significant increase in relation to the normal reference
parameters. On the other hand; highly significant statistical
decrease was found as regards net flow among the studied patients
(Table 4).
In the present study; 25/40 (62.5%) of the included 40 patients
with suspected pulmonary hypertension had normal inter-
ventricular septum (IVS) position, while the remaining 15/40
(37.5%) showed abnormal inter-ventricular septum (IVS) position
(flattened, left bowing or convex towards LV) (Table 5).of cardiovascular magnetic resonance imaging for assessment of right ven-
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.004
Table 5
Evaluation of the inter-ventricular septum (IVS) position among the included 40
patients.
IVS (inter-ventricular septum) position Number of patients
(percentage %)
Normal 25/40 (62.5%)
Abnormal (flattened, left bowing or convex
towards LV)
15/40 (37.5%)
IVS; inter-ventricular septum.
Table 6
Mean values measured by transthoracic echocardiography (TTE).
Echocardiographic parameters Mean ± SD
MPAP, mm Hg 58.21 ± 12.25
TTE-calculated PVR wood 17.2 ± 4.15
TRJV (cm/s) 4.1 ± 0.2
SD; standard deviation, MPAP; mean pulmonary artery pressure, PVR; pulmonary
vascular resistance, TTE; transthoracic echocardiography, mm Hg; millimeter
mercury, TRJV; tricuspid regurgitant jet velocity, cm/s; centimeter per second.
E.R. Ali, A.M. Mohamad / Egyptian Journal of Chest Diseases and Tuberculosis xxx (2016) xxx–xxx 5As regards the mean values measured by transthoracic echocar-
diography (TTE) in the present study it was found that; the
MPAP ± SD was 58.21 ± 12.25, mean TTE-calculated PVR wood
was 17.2 ± 4.15 and mean ± SD tricuspid regurgitant jet velocity
(TRJV) was 4.1 ± 0.2 (Table 6).
In the present study; there was highly significant positive corre-
lation (p value <0.001 for each) between RVEDV and only signifi-
cant positive correlation between RVEDVI (p values were 0.031,
0.054 and 0.328 respectively) and SPAP, mPAP and PVR. RVmass
Index, RVmass and VMI revealed highly significant statistical pos-
itive correlation (p value <0.001 for each) with SPAP, mPAP and
PVR, but highly significant statistical negative correlation (p value
<0.001) was found between RVEF% and SPAP, mPAP and PVR. RVSV.
RVSV and RVSVI showed significant statistical negative correlation
with SPAP, mPAP and PVR (p values were 0.042, 0.032 and 0.021
respectively for RVSV) and (p values were 0. 023, 0.021and 0.054
respectively for RVSVI). As regards average (mean) velocity; highly
significant statistical negative correlation (p value <0.001) was
found between it and SPAP, mPAP and PVR, while significant neg-
ative correlation was found between retrograde flow (PR) (%) and
SPAP, mPAP and PVR (p values were 0.032, 0.021, 0.025 respec-
tively) (Table 7). The most accurate CMRI indices for the detection
of PH in the present study were VMI, RV mass index followed by
RVEF and average velocity with their PPVs were 99%, 98%, 95%
and 95% respectively (Table 8).
In the present study; transthoracic echocardiography (TTE) con-
firmed the diagnosis of pulmonary hypertension (positive) in
31/40 (77.5%) of the studied patients with clinically suspected pul-
monary hypertension, but was negative (no pulmonary hyperten-
sion) among 9/40 (22.5%) of the included patients. On the other
hand; cardiovascular magnetic resonance (CMR) confirmed the
diagnosis of pulmonary hypertension (positive) in 36/40 (90%) of
the studied patients and excluded the diagnosis (negative for pul-
monary hypertension) in the remaining 4/40 (10%) of patients with
clinically suspected pulmonary hypertension as shown in (Tables 9
and 10). The discrepancy between CMRI and TTE as regards the
more positive yield of CMR (that diagnosed 36 cases with pul-
monary hypertension) versus only 31 patients by TTE; this finding
was explained by the fact that; CMR had specific more sensitive
parameters for detection of earlier right ventricular morphological
changes not yet detected by TTE, as VMI (ventricular mass index),
RV mass and late gadolinium enhancement that revealed early
right ventricular remodeling and septal curvature thus explaining
the 5 false negative patients diagnosed by TTE (Table 11).
In the present study; By comparing echocardiographic results
with final diagnosis, there were confirmed diagnosis of pulmonary
hypertension (true positive) in 31 patients and excluded (true neg-
ative) the diagnosis in 4 cases. On the other hand; 5 patients were
found to have no pulmonary hypertension by echo, but CMRITable 4
Mean values of the flow variables (pulmonary artery flow data) measured by CMRI
among the studied 40 patients.
CMRI flow variables
(pulmonary artery flow data)
Mean ± SD Normal
references
Significance
(P value)
Average (mean) velocity (cm/s) 8.98 ± 8.5 13.6 ± 6.7 S
AT (ms) 106.3 ± 18.4 145.7 ± 22 HS
ET (ms) 320.7 ± 54.7 393 ± 74.2 HS
AT/ET ratio 0.29 ± 1.4 0.37 ± 0.08 S
Retrograde flow (PR) (%) 16.3 ± 12.4 9.3 ±7.2 S
Forward flow (ml) 68.8 ± 13.2 110 ± 4.7 S
Backward flow (ml) 15.6 ± 11.6 5 ± 7.5 NS
Net Flow (ml) 53.2 ± 13.7 105 ± 8.9 HS
CMRI; cardiac magnetic resonance imaging, SD; standard deviation, ml; milliliter,
PR; pulmonary regurge; AT; acceleration time, ET; ejection time, ms; millisecond,
cm/s; centimeter/second, NS; non-significant, S; significant, HS; highly significant.
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early pulmonary hypertension, thus echocardiography had 5 false
negative cases with no false positive patients. Thus echocardiogra-
phy had 100% positive predictive value (PPV 100%), 96.8% negative
predictive value (NPV 96.8%) with 88.8% sensitivity, 100% speci-
ficity and 97.5% accuracy. When CMRI results were compared to
final diagnosis; there were 36 patients with confirmed pulmonary
hypertension (true positive), 4 patients with no pulmonary hyper-
tension (true negative), no false negative or false positive results
among the studied patients. Thus CMR had 100% positive predic-
tive value (PPV 100%), 100% negative predictive value (NPV
100%) with 100% sensitivity, 100% specificity and 100% accuracy
(Tables 12 and 13).Discussion
Pulmonary hypertension (PH) is a hemodynamic and patho-
physiologic condition defined as an increase in mean pulmonary
artery pressure (MPAP) of P25 mm at rest as assessed by right-
heart catheterization (RHC) [1]. A progressive rise in pulmonary
vascular resistance (PVR) results from obliteration or obstruction
of pulmonary vascular bed leading to a rise in pulmonary artery
pressure (PAP); these vascular changes result in increased after-
load to the right ventricle (RV) which initially undergoes adaptive
hypertrophy, but later experience.Maladaptive dilatation, fibrosis
and valve regurgitation resulting in right ventricular failure and
early death [2]. Apart from the origin, PH has important impact
on patient’s symptoms and life expectancy. The establishment of
an exact diagnosis and classification, as well as the understanding
of the hemodynamic interrelation provides the basis for often chal-
lenging treatment decisions. The RV is the major determinant of
functional state and prognosis of PH [38]. Although echocardiogra-
phy is the mainstay in the assessment of hemodynamics and ven-
tricular function in PH, MRI has emerged as the gold standard for
quantifying volume, function and flow of the right side of the heart
[39]. The aim of this study was to evaluate the diagnostic accuracy
of a variety of CMR parameters as a non-invasive monitoring to
study the right ventricular function and morphology in patients
with suspected PAH and if it has a role in early recognition and
treatment important to improve long-term outcomes. a total of
40 patients were enrolled in the present study who had undergone
investigation for assessment and diagnosis of suspected PH.
Patients with suspected PH also underwent detailed history andof cardiovascular magnetic resonance imaging for assessment of right ven-
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.004
Table 7
Correlation between MRI parameters and mean pulmonary artery pressure (mPAP), systolic pulmonary artery pressure (SPAP), and pulmonary vascular resistance (PVR) among
the studied population.
Variables SPAP (r value) Significance (P value) mPAP (r value) Significance (P value) PVR (r value) Significance (P value)
MRI parameters
RVEDV 0.043 <0.001 (HS) 0.439 <0.001 (HS) 0.129 <0.001(HS)
RVEDVI 0.078 0.031 (S) 0.213 0.054(S) 0.328 0.034 (S)
RVESV 0.327 0.114 (NS) 0.532 0.102(NS) 0.765 0.428 (NS)
RVESVI 0.264 0.359 (NS) 0.032 0.221(NS) 0.201 0.325 (NS)
RVEF% 0.534 <0.001 (HS) 0.509 <0.001 (HS)  0.321 <0.001 (HS)
RVSV 0.567 0.042 (S) 0.221 0.032 (S) 0.476 0.021 (S)
RVSVI 0.521 0. 023 (S) 0.887 0.021 (S) 0.395 0.054(S)
RV mass 0.321 <0.001 (HS) 0.447 <0.001 (HS) 0.576 <0.001 (HS)
RV mass index 0.109 < 0.001(HS) 0.328 <0.001 (HS) 0.841 <0.001 (HS)
LVED 0.432 0.451 (NS) 0.656 0.654 (NS) 0.342 0.332 (NS)
LVEVI 0.394 0.217 (NS) 0.234 0.332 (NS) 0.398 0.498 (NS)
LVESV 0.324 0.258 (NS) 0.786 0.877 (NS) 0.489 0.321(NS)
LVESVI 0.285 0.372 (NS) 0.221 0.209 (NS) 0.254 0.768(NS)
LVSV 0.129 0.376 (NS) 0.012 0.356 (NS) 0.287 0.554 (NS)
LVSVI 0.238 0.475 (NS) 0.396 0.901 (NS) 0.107 0.436 (NS)
LVEF% 0.335 0.765 (NS) 0.712 0.321 (NS) 0.336 0.543 (NS)
VMI 0.378 <0.001 (HS) 0.877 <0.001 (HS) 0.109 <0.001 (HS)
Average (mean) velocity 0.0213 <0.001 (HS) 0.543 <0.001 (HS) 0.212 <0.001 (HS)
Retrograde flow (PR) (%) 0.304 0.032 (S) 0.649 0.021 (S) 0.224 0.025 (S)
RVEDV; right ventricular end diastolic volume, RVEDVI; right ventricular end diastolic volume index, RVESV; right ventricular end systolic volume, RVEDVI; right ventricular
end systolic volume index, RVSV; right ventricular stroke volume, RVSVI; right ventricular stroke volume index, RVEF%; right ventricular ejection fraction, LVEDV; left
ventricular end diastolic volume, LVEDVI; left ventricular end diastolic volume index, LVESV; left ventricular end systolic volume, LVEDVI; left ventricular end systolic volume
index, LVSV; left ventricular stroke volume, LVSVI; left ventricular stroke volume index, LVEF%; left ventricular ejection fraction, m PAP; mean pulmonary artery pressure,
SPAP; systolic pulmonary artery pressure, SV; stroke volume, RPA; right pulmonary artery, LPA; left pulmonary artery, AA; ascending aorta, PA; pulmonary artery, CMRI;
cardiac magnetic resonance imaging, mPAP; mean pulmonary artery pressure, PVR; pulmonary vascular resistance, NS; non-significant, S; significant, HS; highly significant.
Table 8
Sensitivity, specificity, positive and negative predictive values indices for the
detection of PH by CMRI.
Variables Sensitivity Specificity PPV NPV
Cardiac morphology
RVEDVI 63 54 92 17
RV mass index 89 87 98 42
VMI 84 91 99 41
Right heart functional indices
RVEF 69 76 95 22
RVSVI 70 47 93 24
Phase contrast CMR
Average velocity 89 59 95 28
Retrograde flow 91 68 93 23
RVSVI; right ventricular stroke volume index, RVEDVI; right ventricular end dias-
tolic volume index, VMI; ventricular mass index, RVEF%; right ventricular ejection
fraction, PPV; positive predictive value, NPV; negative predictive values, CMR;
cardiac magnetic resonance.
Table 9
Final diagnosis of the studied patients by transthoracic echocardiography (TTE)
(N = 40).
Echocardiographic results Number (N) = (40
patients)
Percentage
(%)
No pulmonary hypertension
(negative)
9/40 22.5%
Pulmonary hypertension (positive) 31/40 77.5%
%; percentage, N; number.
Table 10
Final diagnosis of the studied patients by cardiovascular magnetic resonance (CMR).
Cardiovascular magnetic resonance
(CMR)
Number (N) = (40
patients)
Percentage
(%)
No pulmonary hypertension
(negative)
4/40 10%
Pulmonary hypertension (positive) 36/40 90%
%; percentage, N; number, CMR; cardiovascular magnetic resonance.
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exertional on less than their ordinary efforts or even dyspnea at
rest, orthopnea and fatigue or weakness) and preliminary investi-
gations including; blood testing, arterial blood gases (ABGs), CXR,
computed tomography scanning, lung function testing, exercise
testing, ECG, transthoracic echocardiogram, cardiac magnetic reso-
nance imaging. Echo and CMR were done and validated by two
independent observers based on the same imaging result (without
any communication). The right and left ventricular parameters
were assessed by CMRI and correlated with SPAP and mPAP
obtained by Echo. SPAP and mPAP measured by Echo have a strong
correlation with right heart catheterization results (RHC) [40]. Car-
diac morphology parameters included: RVEDVI, RV mass index and
VMI. Right heart functional indices included RVEF and RVSVI.
Phase contrast CMR parameters (flow variables) included retro-Table 11
Final diagnosis of the studied 40 patients with suspected pulmonary hypertension.
Final diagnosis Number Percentage (%)
Pulmonary hypertension (positive) 36/40 90%
No pulmonary hypertension (negative) 4/40 10%
%; percentage.
Table 12
Diagnostic sensitivity and specificity of echocardiographic examination according to
final diagnosis.
Echocardiographic results Final diagnosis
No pulmonary
hypertension
Pulmonary
hypertension
No pulmonary hypertension
(negative) (N = 9)
FN = 5 TN = 4
Pulmonary hypertension
(positive) (N = 31)
FP = 0 TP = 31
N; number, FN; false negative, FP; false positive, TN; true negative, TP; true positive.
of cardiovascular magnetic resonance imaging for assessment of right ven-
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.004
Table 13
Diagnostic sensitivity and specificity of CMR according to final diagnosis.
Cardiovascular magnetic
resonance results
Final diagnosis
No pulmonary
hypertension
Pulmonary
hypertension
No pulmonary hypertension
(negative) (N = 4)
FN = 0 TN = 4
Pulmonary hypertension
(positive) (N = 36)
FP = 0 TP = 36
CMR; cardiovascular magnetic resonance, N; number, FN; false negative, FP; false
positive, TN; true negative, TP; true positive.
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(mean) velocity, forward flow, backward flow and net flow. A total
of 40 patients were enrolled in the present study who had under-
gone investigation for assessment and diagnosis of suspected PH.
Patients with suspected PH also underwent detailed history and
full clinical evaluation (usually presented with dyspnea, mostly
exertional on less than their ordinary efforts or even dyspnea at
rest, orthopnea and fatigue or weakness) and preliminary investi-
gations including; blood testing, arterial blood gases (ABGs), CXR,
computed tomography scanning, lung function testing, exercise
testing, ECG, transthoracic echocardiogram, cardiac magnetic reso-
nance imaging. Among the included 40 patients with clinically sus-
pected pulmonary hypertension; 25/40 (62.5%) of them were
males and the remaining 15/40 (37.5%) were females. The mean
age (years) ± SD was 43 ± 18, while the mean weight (kg) ± SD
was 59 ± 16 and the mean height (cm) ± SD was 160 ± 13. Unlike
the study performed by Swift et al. [37] who found female to have
a higher incidence (56%) of PH than males with a more older mean
age than the present study 61 ± 16. In the present study; ventricu-
lar (right and left) volumes, masses and functions by MRI were
compared to the published ventricular volumes and functions in
normal population according to Bogaert et al. [36]. As regards right
ventricular parameters measured by CMRI, there was a statistically
significant increase in RVEDV and RVEDVI but highly significant
increase in RVESV and RVESVI when compared to the normal ref-
erence values. Statistically significant decrease was found in RVSV
and RVSVI and highly significant decrease regarding RVEF% in rela-
tion to the standard normal reference values. Highly significant
statistical increase in RV mass, but RV mass showed only signifi-
cant increase as compared with the reference values. Regarding
the left ventricular parameters measured by CMRI, there was a sta-
tistically non significant increase in LVEDV, LVEDVI, LVESV and
LVESVI when compared to the normal reference values. Statisti-
cally significant decrease was found in LVSV and LVSVI in relation
to the reference values. Non-significant decrease in LVEF% as com-
pared to the standard normal reference values. On the other hand;
highly significant statistical decrease in LV mass was found among
the included patients in relation to normal reference values. In the
present study; 25/40 (62.5%) of the included 40 patients with sus-
pected pulmonary hypertension had normal inter-ventricular sep-
tum (IVS) position, while the remaining 15/40 (37.5%) showed
abnormal inter-ventricular septum (IVS) position (flattened, left
bowing or convex towards LV). These results were in agreement
with Swift et al. [37] who found significantly higher values of
RVEDVI and RV mass were demonstrated in the PH group, and sig-
nificantly lower values of RVEF and RVSVI were found in the PH
group as compared to the ‘No PH’ group and said that; the right
ventricular mass increases over time due to elevated RV afterload
in patients with PH. They postulate that; RVH is an adaptation
mechanism of the RV in order to preserve function. It follows
Laplace’s law that said that; an increase in intra-ventricular pres-
sure results in an increase in wall stress unless the thickness of
the chamber wall is augmented or the internal radius of the cham-Please cite this article in press as: E.R. Ali, A.M. Mohamad, Diagnostic accuracy
tricular morphology and function in pulmonary artery hypertension, Egypt. J.ber is reduced [36]. Thus due to the gradual increase in the PVR, the
RV adapts by thickening of the myocardial wall. The hypertrophy
due to RV overload causes an increase in the cell size of the car-
diomyocytes which in turn increases the diffusion into the cell
[41]. This study was supported by previous works by Kuehne
[42] and Blyth [43] assessing RVEDVI, RV mass index and VMI
which were all found to be elevated in PH when compared to
patients with ‘No PH’, while RVEF and RVSVI were significantly
reduced compared to patients with ‘No PH’. Swift et al. [37]
showed similar results to the present study regarding reduced
RVEF% and mean value which was explained by decreased RVSV
and increased RVEDV (EF = SV/EDVx100) and also due to bowing
of the inter-ventricular septum (IVS) towards the LV. Wolferen
[44] confirmed the present study results as he found RVESV and
RVESVI) to be higher among pulmonary hypertensive patients. This
may be explained by the fact that; an initial adaptive response of
myocardial hypertrophy is followed by progressive contractile dys-
function. Chamber dilatation ensures to allow compensatory pre-
load and maintain stroke volume despite reduced fractional
shortening. As a contractile weakening progresses, clinical evi-
dence of decompensated right ventricular failure occurs, character-
ized by rising filling pressure, diastolic dysfunction and
diminishing stroke volume [45]. Andrew [46] agreed with the pre-
sent study as he found reduced mean RVSV and RVSVI among
patients with PH; a fact that was explained by the decreased con-
tractility and increased afterload and have been shown to correlate
with worse outcome and survival with follow up. As regards LV
affection in patients with PH; the increased PVR limits RVSV and
thus automatically limits the available volume for LV filling, also
IVS bowing to the left side reduces LV volumes in early diastole,
thus representing an adaptive mechanism that further impair LV
filling in the most important phase of rapid filling, thus interfering
with the LV pump function with the resultant reduced LV blood
volume and contractile force, thus confirming LV parameters
obtained by the present study [47]. Also Marrone [48] found that;
increased PVR causes a decrease in RVSV and consequently
decreased LV filing and LVSV. As regards the LV mass parameters;
Swift et al. [37] showed decreased LV mass as in the present study
and concluded that; right ventricular failure following chronic
pressure overload is associated with the reduction in LV mass.
On the other hand; Swift et al. [37] confirmed the increases RV
mass index which is due to increased RV mass. As regards IVS posi-
tion; Marcus [49] and Roeleveld [50] suggested that a SPAP above
60 and 67 mmHg respectively was associated with leftward septal
bowing; a fact may be explained by prolonged RV contraction time
due to reduced RV systolic function leading to IVS mechanical
asynchrony (RV is still contracting as LV enters diastole) causing
leftward bowing towards LV cavity during early diastole. In the
present study; mean values of the flow variables (pulmonary
artery flow data) measured by CMRI among the studied patients
were compared to the published flow variables; there was highly
significant statistical decrease in acceleration time (AT) and ejec-
tion time (ET) and only significant decrease in the average velocity
and AT/ET ratio compared to the published flow variables in nor-
mal population. Retrograde flow (PR) was significantly higher than
the normal reference values. Forward flow was significantly less
than the normal values, while backward flow showed non- signif-
icant increase in relation to the normal reference parameters. On
the other hand; highly significant statistical decrease was found
as regards net flow among the studied patients. These results were
in agreement with Swift et al. [37] who found that patients with PH
have significantly more retrograde PA flow and reduced average PA
velocity than in those without PH. Also Bogaert and Dymarkowski
[36] stated that; pulmonary valve regurgitation is prevalent among
patients with PH and its severity (regurgitation fraction) correlates
with the functional status of the patients. This was in accordanceof cardiovascular magnetic resonance imaging for assessment of right ven-
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.004
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average velocity and AT/ET ratio compared to the published flow
variables in normal population. In the present study; there was
highly significant positive correlation (p value <0.001 for each)
between RVEDV and only significant positive correlation between
RVEDVI (p values were 0.031, 0.054 and 0.328 respectively) and
SPAP, mPAP and PVR. RV mass Index, RV mass and VMI revealed
highly significant statistical positive correlation (p value <0.001
for each) with SPAP, mPAP and PVR, but highly significant statisti-
cal negative correlation (p value <0.001) was found between RVEF%
and SPAP, mPAP and PVR. RVSV and RVSVI showed significant sta-
tistical negative correlation with SPAP, mPAP and PVR (p values
were 0.042, 0.032 and 0.021 respectively for RVSV) and (p values
were 0. 023, 0.021 and 0.054 respectively for RVSVI). As regards
average (mean) velocity; highly significant statistical negative cor-
relation (p value <0.001) was found between it and SPAP, mPAP
and PVR, while significant negative correlation was found between
retrograde flow (PR) (%) and SPAP, mPAP and PVR (p values were
0.032, 0.021, 0.025 respectively).
Sanz [51] confirmed the present study results as he investigated
PA flow characteristics measured with MAI and found that; the
average velocity within the main PA correlated significantly with
the m PAP and resistance. These results were in agreement also
with Saba [52] study who found a significant positive correlation
between RV mass and m PAP. Guo [53] also found significant pos-
itive correlation between VMI and m PAP, thus supporting the pre-
sent study and concluded that; EF was the best parameter
reflecting RV function which could be used to exactly evaluate
RV function in patients with PH. The present study showed. Swift
et al. [37] found a less significant negative correlation between
RVSVI and m PAP as in the present results, confirming our study.
Alunni [54] also found a significant negative correlation between
RVEF and SPAP as in the present study. The most accurate CMRI
indices for the detection of PH in the present study were VMI, RV
mass index followed by RVEF and average velocity with their PPVs
were 99%, 98%, 95% and 95% respectively. This was in agreement
with Swift et al. [37] who found VMI also demonstrated the highest
diagnostic accuracy for the diagnosis of PH of all measured MR
indices. In addition, late gadolinium enhancement at the interven-
tricular hinge points was sensitive and specific for the identifica-
tion of PH and was present in 95% of patients with IPAH,
supporting a role for the routine measurement of these MR metrics
in patients undergoing diagnostic CMR evaluation for suspected
pulmonary hypertension. Beygui [55] study also found CMR to pro-
vide accurate and reproducible measurements of RV morphology
and function, including mass, RVEDVI, RVEF, and RVSVI. In the pre-
sent study; transthoracic echocardiography (TTE) confirmed the
diagnosis of pulmonary hypertension (positive) in 31/40 (77.5%)
of the studied patients with clinically suspected pulmonary hyper-
tension, but was negative (no pulmonary hypertension) among
9/40 (22.5%) of the included patients. On the other hand; cardio-
vascular magnetic resonance (CMR) confirmed the diagnosis of
pulmonary hypertension (positive) in 36/40 (90%) of the studied
patients and excluded the diagnosis (negative for pulmonary
hypertension) in the remaining 4/40 (10%) of patients with clini-
cally suspected pulmonary hypertension. In the present study; By
comparing echocardiographic results with final diagnosis, there
were confirmed diagnosis of pulmonary hypertension (true posi-
tive) in 31 patients and excluded (true negative) the diagnosis in
4 cases. On the other hand; 5 patients were found to have no pul-
monary hypertension by echo, but CMRI showed morphological
right ventricular changes consistent with early pulmonary hyper-
tension, thus echocardiography had 5 false negative cases with
no false positive patients. Thus echocardiography had 100% posi-
tive predictive value (PPV 100%), 96.8% negative predictive value
(NPV 96.8%) with 88.8% sensitivity, 100% specificity and 97.5%Please cite this article in press as: E.R. Ali, A.M. Mohamad, Diagnostic accuracy
tricular morphology and function in pulmonary artery hypertension, Egypt. J.accuracy. When CMRI results were compared to final diagnosis;
there were 36 patients with confirmed pulmonary hypertension
(true positive), 4 patients with no pulmonary hypertension (true
negative), no false negative or false positive results among the
studied patients. Thus CMR had 100% positive predictive value
(PPV 100%), 100% negative predictive value (NPV 100%) with
100% sensitivity, 100% specificity and 100% accuracy. Early more
sensitive CMRI results were confirmed by Sanz et al. study [56]
who found PA stiffens before pulmonary artery pressure increase
at rest (through measuring the istensibility of pulmonary arteries).
Marcus et al. [57] found V mass index (VMI) to be a highly sensitive
early detector for screening of pulmonary hypertension among
clinically suspected patients. Kuehne et al. [58] concluded that;
interventricular dyssnchrony and septal bowing were early predic-
tor for PAH and were due to slower contraction for the RV than LV
(measured as an MRI tagging sign). Sanz et al. [59] and
Muthurangu et al. [60] found early more sensitive predictor as dis-
connect that occurred since increases in arterial load are far greater
than those in contractility (measured by volumes combined with
invasively derived pressure loops/pressures). Peacock and Vonk
Noordegraaf [61] stated that pulmonary vascular resistance
derived from the Fick method is inaccurate in conditions of vasodi-
latation (flow combined with invasively derived pressure and
could be substituted by CMR which is now considered the gold
standard for measuring ventricular volume, mass and structure
as well. Freed et al. [62] concluded that; contrast-enhanced
CMRILGE at the right ventricle insertion point was an early more
sensitive marker than echo for earlier detection of PH and is related
to clinical worsening. Finally, Garcia et al. [63] found that; myocar-
dial T1 mapping enables quantification of myocardial extracellular
volume; may be useful for detecting the early stages of chronic PH
prior to the onset of macroscopic fibrosis.Conclusion
Although right heart catheterization (RHC) remains the gold
standard for the assessment of pulmonary hemodynamics but it
is invasive and echocardiography is routinely used for clinical prac-
tice, evaluation and management of PH but it has limitations in
assessment of the RV. CMRI has a number of advantages over other
techniques. It is non-invasive, nontoxic contrast agents and
does not use ionizing radiation, provides high resolution,
3-dimensional images that avoid the need for geometric assump-
tions that are required for some calculations in echocardiography,
allowing accurate measurement and monitoring and quantification
the right ventricle of chamber volumes, myocardial mass and
trans-valvular flow. So, CMR imaging is likely to increase in impor-
tance as the optimal reference method for assessment of early
structural (morphological) and functional parameters of the right
ventricle for evaluation of patients with suspected PH valuable
for assessment of treatment response, follow up and prognosis.
RV mass, VMI, RVEF and late gadolinium enhancement could be
considered accurate sensitive predictors for the degree and sever-
ity of PH and useful for follow up as prognostic parameters. MRI is
an accurate more sensitive alternative to echocardiography in the
evaluation of patients with suspected PH. VMI showed highest
accuracy of all CMRmeasurements for the identification of PH. Late
gadolinium enhancement is a new useful markers that should be
evaluated and studied more in patients with suspected pulmonary
hypertension.References
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